chrisvoncsefalvay/vaers-outcomes huggingface dataset:
felt cold; sick to my stomach; felt weak/felt weak in the legs; felt sick; arm hurt up to the shoulder and down to my elbow; could hardly sleep; ached everywhere; felt tiredness; felt like I had a fever; head hurt; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (felt cold), ABDOMINAL PAIN UPPER (sick to my stomach), ASTHENIA (felt weak/felt weak in the legs), ILLNESS (felt sick) and PAIN IN EXTREMITY (arm hurt up to the shoulder and down to my elbow) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FEELING COLD (felt cold), ABDOMINAL PAIN UPPER (sick to my stomach), ASTHENIA (felt weak/felt weak in the legs), ILLNESS (felt sick), PAIN IN EXTREMITY (arm hurt up to the shoulder and down to my elbow), INSOMNIA (could hardly sleep), PAIN (ached everywhere), FATIGUE (felt tiredness), PYREXIA (felt like I had a fever) and HEADACHE (head hurt). At the time of the report, FEELING COLD (felt cold), ABDOMINAL PAIN UPPER (sick to my stomach), ASTHENIA (felt weak/felt weak in the legs), ILLNESS (felt sick), PAIN IN EXTREMITY (arm hurt up to the shoulder and down to my elbow), INSOMNIA (could hardly sleep), PAIN (ached everywhere), FATIGUE (felt tiredness), PYREXIA (felt like I had a fever) and HEADACHE (head hurt) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   not concomitant was recorded. not treatment  was recorded This case concerns a  71-year-old, female patient with no relevant medical history, who experienced the unexpected events of Abdominal pain upper, Feeling cold, Asthenia, Illness, Pain in extremity, Insomnia and Pain; and the expected events of Fatigue, Headache, Pyrexia. The events occurred on an unknown date after the first dose of Moderna CoviD-19 Vaccine. The rechallenge was not applicable as the events that occurred in  this case was referring  to the first dose. The benefit-risk relationship of Moderna CoviD-19 Vaccine is not affected by this report.   This case was linked to MOD-2021-377968, MOD-2021-377972 (Patient Link).; Sender's Comments: This case concerns a  71-year-old, female patient with no relevant medical history, who experienced the unexpected events of Abdominal pain upper, Feeling cold, Asthenia, Illness, Pain in extremity, Insomnia and Pain; and the expected events of Fatigue, Headache, Pyrexia. The events occurred on an unknown date after the first dose of Moderna CoviD-19 Vaccine. The rechallenge was not applicable as the events that occurred in  this case was referring  to the first dose. The benefit-risk relationship of Moderna CoviD-19 Vaccine is not affected by this report.
Pt had 1st flu shot. C/o skin tingling & itchiness, red arm, warm to touch & minor hives.  Took benadryl. States has allergies to jalopeno, brocolli, & bees 10/21 F/U call - arm hot to touch 10/22 F/U call - welt started,  10/23 F/U call - not hot or swelling
1st dose of Shingrix in 2019 and 2nd dose of Shingrix on May 5, 2022; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 67-year-old male patient who received Herpes zoster (Shingrix) (batch number 54TF4, expiry date 18th May 2023) for prophylaxis.   Previously administered products included Shingrix (1st dose received in 2019, date, lot number and expiration date was unknown).   On 5th May 2022, the patient received the 2nd dose of Shingrix. On 5th May 2022, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.       Additional Information: GSK Receipt Date: 14-Jul-2022 Reporter's comment: The Doctor wanted patient to had his 3rd Shingrix vaccine.  Patient had not been administered the 3rd Shingrix vaccine at time of call.  The consent to follow-up was given. Additional Supportive Information: The patient received 1st dose of Shingrix in 2019 and 2nd dose of Shingrix on 5th May 2022, which led to lengthening of the vaccine schedule.
24hrs after vaccines, baby had runny, large stools with mucous. Lasted 3 days.
Nasal congestion; Dizziness; Heart palpitations; Nausea; Joint pain; Headache; Tiredness; Pain and swelling at injection site; Pain and swelling at injection site; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 08Apr2021 at 15:45 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. The patient had not reported any other health issues. The patient had no known allergies to medications, food, or other products. Concomitant medications included vitamin d nos (VITAMIN D) and multivitamins from an unknown date for an unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on an unknown date as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 09Apr2021 at 10:00, the patient experienced dizziness, nausea, joint pain, headache, heart palpitations, tiredness, pain and swelling at injection site, nasal congestion. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of reported events which included treatment with unspecified emergency medical treatment (EMT). The clinical outcomes of dizziness, nausea, joint pain, headache, heart palpitations, tiredness, pain and swelling at injection site, nasal congestion were recovering at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Severe rash with welts over 80% of body, including ear canals, eyes, throat, and vagina. Lasting 6 days.
After I received the first dose, I almost immediately felt pain in my elbow.  It happened when I was waiting 15 minutes.  I didn't say anything because I was told that my arm would most likely be very sore, so I thought it was just that.   There wasn't pain at the injection site, but only concentrated in my elbow.   I can only describe it as if you whack your elbow into a corner of a wall and you get that pain/tingly funny bone sensation.   It's painful, a little numb and sometimes even difficult to extend and bend my arm at the elbow joint.   And sometimes difficult to grip my left hand.   After about 2 weeks of having this pain, I realized that my 2nd shot was coming up.   I thought it was weird that I still had pain but so many people had told me about sore arms, I didn't think much of it at the time.  So I tried calling my doctor, however I found that she had left the practice and I couldn't get in to see anyone before my 2nd shot.   I was told by that office to just go ahead and get the 2nd shot.   I did 2nd on May 2nd and I explained to the nurse there what had happened and she did the shot in my right arm, and I have had zero issues.   She advised me to see a doctor about my left arm and thought it could be nerve damage.   Since I no longer had a doctor, I had to find a new practice and I have an appointment next week to talk to them about this.   I couldn't reach anyone at the vaccine clinic and was only told to "see my doctor".   I wish there was better direct follow up with all of these mass vaccine clinics
Patient has redness and swelling of the upper left arm and the redness extends to the chest area. Warmth and pain.
Dar reported patient "almost passed out" and patient stated he had headache. I observed the patient to be alert/ appropriately responsive.
PT HUSBAND STATES THAT SHE BROKE OUT IN A SYSTEMIC RASH ON HER STOMACH AND ARMS. HE IS AN RPH AND STATES THEY REPORTED IT TO VAERS AS WELL.
This spontaneous report has been received from a medical assistant referring to a 25 year old patient of unknown gender. The patient's medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not reported. On unspecified dates in 2013, the patient received the first and second doses of GARDASIL (strength, dose, route, lot #, expiration date or anatomical location were not reported) for prophylaxis. Later, on 04-APR-2017, the patient received a dose of GARDASIL 9 (strength, dose, route, lot #, expiration date or anatomical location were not reported) for prophylaxis. No adverse effects were reported. Additional information has been requested.
Flushing to face, neck, and chest; Rash to face, neck, and chest, dizziness, tingling to upper torso and face, elevated BP, red welp and knot at injection site. Give 40mg Prednisone and SQ injection of epinephrine sent home with prescriptions for prednisone 5 days, ranitidine and vistaril.
currently it's my shoulder. The pain comes periodically/at the wrist pain and upper muscle where the shot was given/pain was in her shoulder, upper muscles, wrist, elbow, mostly on her arm- her wrist, middle finger, and thumb; at the wrist pain and upper muscle where the shot was given; throbbing; pain was in her shoulder, upper muscles, wrist, elbow, mostly on her arm- her wrist, middle finger, and thumb; pain was in her shoulder, upper muscles, wrist, elbow, mostly on her arm- her wrist, middle finger, and thumb; This is a spontaneous report from a contactable consumer or other non hcp (patient herself) via medical information team. A 50-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EN6202, Expiry date: Unknown) via an unspecified route of administration on 09Mar2021 as dose 1, single (at the age of 50-years-old) for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On 12Mar2021, the patient experienced currently it's my shoulder, the pain comes periodically/at the wrist pain and upper muscle where the shot was given/pain was in her shoulder, upper muscles, wrist, elbow, mostly on her arm- her wrist, middle finger, and thumb, at the wrist pain and upper muscle where the shot was given, throbbing, pain was in her shoulder, upper muscles, wrist, elbow, mostly on her arm- her wrist, middle finger, and thumb, pain was in her shoulder, upper muscles, wrist, elbow, mostly on her arm, her wrist, middle finger, and thumb. Therapeutic measures were taken which included ibuprofen, she took ibuprofen in the night but, she don't want to continue to take it to get relief from it. Patient received treatment for the events. The outcome of events was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be requested. No further information is expected.
Started with chills, headache, puffy/swollen face to blisters on my inner thighs which have now popped and are extremely painful and very tender to the touch
This spontaneous report as received from a nurse practitioner refers to an unspecified number of patients. On unknown dates the patients were vaccinated with doses of M-M-R II, injection, (lot # , expiration date and dose unspecified) that were exposed to 8.5 degree centigrade to 12 degree centigrade for 158.5 hours, which was an excursion that was not supported by in-house stability data. No adverse effect reported. This is one of several reports received from same source. Additional information has been requested.
Nausea/Vomiting; Severe Chills; Fever; Pain at Injection Site; Muscular Pain/Extreme Sensitivity to Touch; Menstrual Cycle Stopped Suddenly/Severe Cramps; Headache; Loss of Taste; Chest Pain
second dose is given 2 weeks after the first; This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose is given 2 weeks after the first) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose is given 2 weeks after the first). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose is given 2 weeks after the first) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment reported.   Reporter did not allow further contact
This case was reported by a consumer via call center representative and described the occurrence of myalgia in a 68-year-old male patient who received SHINGRIX for prophylaxis. On 28th August 2018, the patient received the 1st dose of SHINGRIX (intramuscular). On 28th August 2018, less than a day after receiving SHINGRIX, the patient experienced myalgia, malaise, loss of energy, injection site pain, tiredness, headache, fever, decreased appetite and feeling abnormal. On an unknown date, the outcome of the myalgia, malaise, loss of energy, injection site pain, tiredness, headache, fever, decreased appetite and feeling abnormal were recovering/resolving. It was unknown if the reporter considered the myalgia, malaise, loss of energy, injection site pain, tiredness, headache, fever, decreased appetite and feeling abnormal to be related to SHINGRIX. Additional details were provided as follows: The patient experienced weakness, low appetite and no energy. The patient also experienced pain at the injection site. The patient did not feel like doing much of anything over the next 2 days. The patient felt better on the day of reporting, but not fully recovered.
Vaccines given on 6/22/01. Parent called on 6/29/01, stating that pt had a febrile seizure, the night after vaccines given. Called 911 and O2 was given. Sat 95%.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On 26-MAR-2015, the patient was vaccinated with expired dose of (Oka/Merck) VARIVAX (lot # J002317, expiration date 22-FEB-2015, subcutaneously, dose was not provided) in error. There were no known adverse effects. All of the data was reconfirmed with the reporter. There was no further information provided. Additional information has been requested.
This spontaneous report was received from a certified Medical Assistant via company representative regarding a 60 year old female patient. There was no information about concurrent condition and historical medication. On 28-DEC-2015, the patient who was intended to receive ZOSTAVAX was inadvertently administered vaccinated with VARIVAX (Merck) (wrong drug administered). No concomitant medication was reported. No adverse event was reported. The outcome of the event was unknown. Additional information has been requested.
patients received doses from an expire vial; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patients received doses from an expire vial) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 054C21A and 054C21A) for COVID-19 vaccination.     The patient's past medical history included Lumbar radiculopathy. Concomitant products included SERTRALINE from 09-Jun-2021 to an unknown date and OXAPROZIN from 27-Jan-2020 to an unknown date for an unknown indication.   On 27-May-2021 at 3:06 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jun-2021 at 1:01 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (patients received doses from an expire vial). On 24-Jun-2021, EXPIRED PRODUCT ADMINISTERED (patients received doses from an expire vial) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information provided
Vaccine at 11:05 on 3/16/21  12:00pm- rolling chills started and persisted along with intense arm pain from the shoulder to the elbow. It is difficult to lift the arm of the shot and it cannot hold any weight.   Tinnitus- started at 11:56pm with sounds of white noise rising loudly in my ears along with feeling very hot and nauseate. I could not stand because I felt so dizzy until 2pm the following day (3/17/2021).  Nausea continued along with increased heart rate and pain in abdomen and chest  Frequent Muscle spasms in back, legs, and abdomen.   As of 3/18/21 the sound in my ears has not subsided.
the bleeding has not stopped for approximately 100 days; This is a spontaneous report received from a contactable consumer (patient) via company representative. A 21-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), on 12Apr2021 as dose 2, single for COVID-19 immunisation. The patient's medical history was not reported. The patient's concomitant medications included levetiracetam (KEPPRA), from unspecified date. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), on unspecified date as dose 1, single for COVID-19 immunization. It was reported that patient received second dose on 12Apr2021 and on 26Apr2021 began menstruating (normal cycle time) but the bleeding had not stopped for approximately 100 days. She took KEPPRA. Otherwise healthy and normal. The event took place after use of product. The outcome of the event was unknown.  Information on lot/batch number has been requested.
Patient claims via email: "My left arm has gotten progressively worse in terms of pain and range of motion. Initially there was no reaction but then approximately a week later I noticed some stiffness in the shoulder area. This has gotten to the point that I can't raise my arm to shoulder level or reach out to the side with that arm. I called my doctor and they think that that it is an injection site injury. They suggested I contact HR. Hence this message. I have not fallen, strained the arm, bruised it or any other thing that I can think of as to why it is so painful.. The only thing that seems to fit is the shot." Adverse reaction was brought to our attention on 10/22/18. Followed up and spoke with patient on 10/24/2018. Patient claims to have slowly regained range of motion, but will keep appointment with primary doctor for follow-up.
HCP said she was giving her 0.25mcg for the booster; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL UNDERDOSE (HCP said she was giving her 0.25mcg for the booster) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 microgram. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (HCP said she was giving her 0.25mcg for the booster). At the time of the report, ACCIDENTAL UNDERDOSE (HCP said she was giving her 0.25mcg for the booster) had resolved.            No concomitant products were reported. No treatment information was reported by the reporter.   Reporter did not allow further contact
4 1/2 x 3" edema of lt upper arm; 1st acP vaccine; finished w/series; no prior rxn;
injection site soreness fever - 101, headache, tired, sleepy muscle pain, joint pain all over a period of 24-36 hours
LOCALIZED SWELLING, REDNESS, WARM TO TOUCH; APPROX 10CM IN DIAMETER.
low oxygen; high heart rate; cough; This is a spontaneous report from a contactable (patient). A 79-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EL9262, Expiration date: Unknown), via an unspecified route of administration on 25Jan2021 (at the age of 79-year-old) as dose 1, single for covid-19 immunisation in hospital. Medical history included diabetes mellitus from 2011 and ongoing (10 years ago), chronic obstructive pulmonary disease from 2016 to an unknown date (5 years ago), high blood pressure from 2011 and ongoing (10 years back) , prostate issues (10 years ago). Concomitant medication(s) included METFORMIN 500 mg, twice a day taken for diabetes mellitus; salbutamol sulfate (ALBUTEROL [SALBUTAMOL SULFATE]) taken for an unspecified indication from an unspecified start date and ongoing; FINASTERIDE 5mg, once a day taken for an unspecified indication; TAMSULOSIN once a day taken for an unspecified indication; METOPROLOL 50mg, once a day taken for hypertension all from an unspecified start date and stop date, ATORVASTATIN once a day taken for an unspecified indication from 2016 to an unspecified stop date. On an unspecified date in 2021, the patient experienced low oxygen, high heart rate and cough. He went to emergency and he was treated there, and he was okay the next day. Patient reported that he experienced side effects after his first dose of the Pfizer covid 19 vaccine that he received on 25Jan2021. Patient reported that he had a high heart rate low oxygen and a cough the next day. Patient went to the ER for 4-5 hours. Patient stated that he tested negative for covid, but his MD told him he probably had covid. Patient wanted to know if he should get the second dose due to the side effects and due to him possibly having covid. Patient stated, he just wanted to report adverse effect he had from his first Pfizer shot and he was wondering if he should get the second one or if he can wait for 3 months. The patient underwent lab tests and procedures which included blood test: unknown results on an unspecified date, heart rate: high: reported that he had a high heart rate low oxygen and a cough the next day, on an unspecified date, oxygen saturation: low on an unspecified date, sars-cov-2 test: negative on an unspecified date: Patient stated that he tested negative for covid, but his MD told him he probably had covid. Therapeutic measures were taken as a result of the events. Regarding treatment the patient stated that, he did not know. They gave him an IV in the hospital. That's all he did remember. It was not like he was dehydrated. The outcome of the events was unknown.  Follow-up attempts completed. No further information expected.
pt recv vax 21APR98 & the following day pt exp pain in arm noting can't move it;23APR98 pt devel a rash & welts & noted can now move arm;